Published in Gut on February 01, 1974
Why portal hypertensive varices bleed and bleed: a hypothesis. Gut (1995) 1.10
Splanchnic vasodilation and hyperdynamic circulatory syndrome in cirrhosis. World J Gastroenterol (2014) 0.90
Effect of portal venous blood flow diversion on portal pressure. J Clin Invest (1980) 0.88
Significance of corrected sinusoidal pressure (CSP) in patients with cirrhosis and portal hypertension. Ann Surg (1981) 0.79
Treatment of resistant ascites by continuous ultrafiltration--reinfusion of ascitic fluid. Can Med Assoc J (1977) 0.78
The hepatic vasculature and its response to hepatic injury: a working hypothesis. Yale J Biol Med (1978) 0.78
Relationship of splanchnic blood flow and portal venous resistance to elevated portal pressure in the dog. Gut (1976) 0.77
Coagulopathy in liver disease: Lack of an assessment tool. World J Gastroenterol (2015) 0.76
Gastroesophageal variceal hemorrhage: pathogenesis and management. West J Med (1979) 0.75
Effect of peritoneo-venous shunt on portal pressure. Gut (1989) 0.75
The international normalized ratio does not reflect bleeding risk in esophageal variceal hemorrhage. Saudi J Gastroenterol (2015) 0.75
A clinical investigation of the portacaval shunt. V. Survival analysis of the therapeutic operation. Ann Surg (1971) 2.46
Portal tension and its dependence on external pressure. Ann Surg (1954) 1.98
Plasma volume in cirrhosis of the liver: its relation of portal hypertension, ascites, and renal failure. J Clin Invest (1967) 1.78
Studies on portal hypertension. IV. The clinical and physiopathologic significance of self-established (nonsurgical) portal systemic venous shunts. Ann Surg (1959) 1.71
Compartmentalization of ascites and edema in patients with hepatic cirrhosis. N Engl J Med (1970) 1.58
Hemodynamic and metabolic effects of hemorrhage in man, with particular reference to the splanchnic circulation. Circ Res (1966) 1.30
Effect of lymph drainage on portal pressure and bleeding esophageal varices. Gastroenterology (1969) 1.23
Effect of plasma-volume expansion on portal hypertension. N Engl J Med (1966) 0.96
Intravenous albumin in the treatment of diuretic-resistant ascites in portal cirrhosis. Lancet (1961) 0.93
Relative value of central-venous-pressure monitoring and blood-volume measurement in the management of shock. Lancet (1968) 0.86
Clinical assessment of postoperative blood volume. Lancet (1972) 0.83
Growth characteristics of group A streptococci in a new chemically defined medium. Infect Immun (1980) 5.90
Plasmid content of Streptococcus faecalis strain 39-5 and identification of a pheromone (cPD1)-induced surface antigen. J Gen Microbiol (1983) 3.80
Comparison of a new cephalosporin, BMY 28142, with other broad-spectrum beta-lactam antibiotics. Antimicrob Agents Chemother (1985) 2.87
Type B hepatitis after needle-stick exposure: prevention with hepatitis B immune globulin. Final report of the Veterans Administration Cooperative Study. Ann Intern Med (1978) 2.29
BMY 28100, a new oral cephalosporin. Antimicrob Agents Chemother (1987) 2.03
Precursor-product relationship of intracellular and extracellular lipoteichoic acids of Streptococcus faecium. J Bacteriol (1979) 1.97
Affinity of cephalosporins for beta-lactamases as a factor in antibacterial efficacy. Antimicrob Agents Chemother (1986) 1.95
Identification of pheromone-induced surface proteins in Streptococcus faecalis and evidence of a role for lipoteichoic acid in formation of mating aggregates. J Bacteriol (1986) 1.90
Identification and partial characterization of a pheromone-induced adhesive surface antigen of Streptococcus faecalis. J Bacteriol (1983) 1.86
Efficacy of hepatitis B immune serum globulin after accidental exposure. Preliminary report of the Veterans Administration Cooperative Study. Lancet (1975) 1.59
Direct quantitation of the number of individual penicillin-binding proteins per cell in Escherichia coli. J Bacteriol (1996) 1.57
Activity of cefepime against ceftazidime- and cefotaxime-resistant gram-negative bacteria and its relationship to beta-lactamase levels. Antimicrob Agents Chemother (1989) 1.55
Efficacy of cefepime in the treatment of infections due to multiply resistant Enterobacter species. Clin Infect Dis (1996) 1.41
In vitro antifungal and fungicidal spectra of a new pradimicin derivative, BMS-181184. Antimicrob Agents Chemother (1995) 1.39
Specific inhibition of gastric pepsin in the treatment of gastric ulcer. Gastroenterology (1969) 1.33
Characterization and localization of the enzymatic deacylation of lipoteichoic acid in group A streptococci. J Exp Med (1979) 1.29
Complications of endoscopic retrograde cholangiopancreatography. Analysis of 300 consecutive cases. Gastroenterology (1975) 1.24
Chemical analysis of changes in membrane composition during growth of Streptococcus pyogenes. Infect Immun (1979) 1.24
Effect of lymph drainage on portal pressure and bleeding esophageal varices. Gastroenterology (1969) 1.23
Comparison of cefepime, cefpirome, and cefaclidine binding affinities for penicillin-binding proteins in Escherichia coli K-12 and Pseudomonas aeruginosa SC8329. Antimicrob Agents Chemother (1991) 1.13
Quantitative immunoelectrophoretic analysis of Streptococcus pyogenes membrane. Infect Immun (1979) 1.13
Identification and characterization of cell wall-cell division gene clusters in pathogenic gram-positive cocci. J Bacteriol (1997) 1.13
Frequency of in vitro resistance of Pseudomonas aeruginosa to cefepime, ceftazidime, and cefotaxime. Antimicrob Agents Chemother (1988) 1.08
Enzymatic deacylation of lipoteichoic acid by protoplasts of Streptococcus faecium (Streptococcus faecalis ATCC 9790). J Bacteriol (1979) 1.07
Umbilical vein catheterization in man. Surg Gynecol Obstet (1967) 1.05
A randomized, double blind controlled trial of the efficacy of immune serum globulin for the prevention of post-transfusion hepatitis. A Veterans Administration cooperative study. Gastroenterology (1977) 1.04
Evaluation of anticancer drugs by umbilical vein hepatography. Cancer (1967) 1.00
Effects of substitution on polyglycerol phosphate-specific antibody binding to lipoteichoic acids. Infect Immun (1983) 0.99
Endoscopic papillotomy for choledocholithiasis. N Engl J Med (1975) 0.97
Activity of carbapenem BMS-181139 against Pseudomonas aeruginosa is not dependent on porin protein D2. Antimicrob Agents Chemother (1995) 0.96
Umbilical vein angiography. Radiology (1966) 0.95
Differences in the resistant variants of Enterobacter cloacae selected by extended-spectrum cephalosporins. Antimicrob Agents Chemother (1996) 0.92
The use of lectins in the quantitation and analysis of macromolecules by affinoelectrophoresis. Anal Biochem (1977) 0.92
Endoscopic retrograde cholangiopancreatography (ERCP) in the diagnosis of pancreatic inflammatory disease. Radiology (1974) 0.90
Indications, clinical value and complications of endoscopic retrograde cholangiopancreatography. Surg Gynecol Obstet (1976) 0.88
Effect of portal venous blood flow diversion on portal pressure. J Clin Invest (1980) 0.88
beta-Lactamase parameters of heterogeneously and homogeneously methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother (1993) 0.88
Therapeutic studies of cefepime (BMY 28142) in murine meningitis and pharmacokinetics in neonatal rats. Antimicrob Agents Chemother (1990) 0.87
Fluoronaphthyridines and quinolones as antibacterial agents. 2. Synthesis and structure-activity relationships of new 1-tert-butyl 7-substituted derivatives. J Med Chem (1990) 0.87
Advances in the management of bile duct obstruction: percutaneous transhepatic cholangiography and endoscopic retrograde cholangiopancreatography. Med Clin North Am (1979) 0.86
Crossed immunoelectrophoresis from sodium dodecyl sulfate- polyacrylamide gels after fixation and staining and without nonionic detergent intermediate layers. Anal Biochem (1981) 0.86
Increased carbohydrate substitution of lipoteichoic acid during inhibition of protein synthesis. J Bacteriol (1983) 0.86
Limulus lysate activity of lipoteichoic acids. J Dent Res (1977) 0.86
In vitro and in vivo antibacterial activities of BMY 40062, a new fluoronaphthyridone. Antimicrob Agents Chemother (1989) 0.85
Inability of cephalothin testing to predict cefprozil susceptibility. J Clin Microbiol (1991) 0.85
Editorial: Scanning the portal circulation. Gastroenterology (1974) 0.85
Pathogenesis of precirrhotic portal hypertension in alcohol-fed baboons. Gastroenterology (1985) 0.84
Effects of penicillin on group A streptococci: loss of viability appears to precede stimulation of release of lipoteichoic acid. Antimicrob Agents Chemother (1981) 0.84
Pretreatment with lipoteichoic acid sensitizes target cells to antibody-dependent cellular cytotoxicity in the presence of anti-lipoteichoic acid antibodies. Infect Immun (1985) 0.84
Hemodynamic factors reflect prognosis after portal caval shunt. Surg Forum (1972) 0.83
Management of biliary calculi by retrograde endoscopic instrumentation (lithocenosis). Gastrointest Endosc (1976) 0.82
Value, complications, and limitations of umbilical vein catheterization. Surg Gynecol Obstet (1973) 0.82
Retrograde flow of portal vein blood in patients with cirrhosis. Radiology (1969) 0.82
The endoscopic intrahepatic cholangiogram. Clinicopathologic correlation with postmortem cholangiograms. Invest Radiol (1976) 0.81
Glucan-binding factor in saliva. Infect Immun (1988) 0.81
Fluoronaphthyridines as antibacterial agents. 4. Synthesis and structure-activity relationships of 5-substituted-6-fluoro-7-(cycloalkylamino)-1,4-dihydro-4-oxo-1,8- naphthyridine-3-carboxylic acids. J Med Chem (1992) 0.81
Endoscopy: a dominant influence in the gastroenterology job market. N Engl J Med (1977) 0.81
Alternatives to cholecystectomy and common duct exploration. Am J Gastroenterol (1988) 0.80
Endoscopy and retrograde cholangiography via gastrostomy. Gastrointest Endosc (1975) 0.80
In vitro and in vivo evaluations of a new broad-spectrum oral cephalosporin, BMY-28232, and its prodrug esters. Antimicrob Agents Chemother (1989) 0.79
Quantitation of effects of subinhibitory concentrations of trimethoprim on P fimbria expression and in vitro adhesiveness of uropathogenic Escherichia coli. J Clin Microbiol (1988) 0.79
Structure-activity relationships of carbapenems that determine their dependence on porin protein D2 for activity against Pseudomonas aeruginosa. Antimicrob Agents Chemother (1995) 0.79
Emergence of homogeneously methicillin-resistant Staphylococcus aureus. J Clin Microbiol (1991) 0.79
Endoscopic retrograde cholangiopancreatography in the dog: a model for training and research. Gastrointest Endosc (1974) 0.79
The clinical value of endoscopic retrograde cholangiopancreatography. Bull N Y Acad Med (1975) 0.78
Oxyhemoglobin dissociation in patients with hepatic encephalopathy. Gastroenterology (1967) 0.78
Pumping portal blood for therapy and knowledge. J Hepatol (1996) 0.78
Endoscopy with endoscopic cholangiopancreatography. The combination as a primary diagnostic procedure. JAMA (1975) 0.78
Radiology of papilla of Vater stenosis. Gastrointest Radiol (1978) 0.78
To cannulate. Gastroenterology (1973) 0.78
The effect of a hydrocholeretic agent (Zanchol) on biliary lipids in post cholecystectomy patients. Gastroenterology (1976) 0.78
The hepatic vasculature and its response to hepatic injury: a working hypothesis. Yale J Biol Med (1978) 0.78
Effect of umbilico-systemic shunting on portal pressure and bleeding varices. Surg Forum (1969) 0.77
Injection pistol for volume control of contrast injection during endoscopic retrograde cholangiopancreatography. Gastrointest Endosc (1987) 0.77
Amylopectin sulphate (SN-263) coats the gastric mucosal surface. Gut (1973) 0.77
Development of resistance in Pseudomonas aeruginosa to broad-spectrum cephalosporins via step-wise mutations. J Antimicrob Chemother (1993) 0.77
Endoscopic stents and drains in the management of pancreatic and bile duct obstruction. Surg Clin North Am (1982) 0.77
Filtration of schistosomes in unanesthetized man. JAMA (1970) 0.77
Interaction of anti-kojibiose antibody with the lipoteichoic acids from Streptococcus faecalis and Streptococcus faecium. Infect Immun (1984) 0.77
Comparison of the inhibitory and bactericidal activity of aztreonam and amikacin against gram negative aerobic bacilli. Ann Clin Lab Sci (1989) 0.77
In vitro activities of cefepime alone and with amikacin against aminoglycoside-resistant gram-negative bacteria. Antimicrob Agents Chemother (1991) 0.75
The umbilical vein in diseases of the liver. Bull N Y Acad Med (1967) 0.75
Albumin to ascites: demonstration of a direct pathway bypassing the systemic circulation. J Clin Invest (1969) 0.75